BioHealth Innovation announced that big pharma, Roche entered into an agreement to advance healthcare technologies coming from academic institutions, federal laboratories and startups based in Central Maryland. Read the full story

A form of partnership where the parties agree to work collaboratively... Read the full story

Protea Biosciences and InSphero have entered into a collaboration that will combine each company's respective 3D technology. Read the full story

Carestream Health has been awarded an extension of its contract with the U.S. Defense Department that allows the federal government and federal agencies to spend up to $70.2 million for digital radiography and computed radiography medical imaging systems. Read the full story

Cadila Pharmaceuticals and Helperby Therapeutics have signed a joint agreement on antibiotic drug resistance Research & Development. Read the full story

Evotec announced a collaboration with the Johnson & Johnson Innovation Center in California to identify new targets for Alzheimer's disease drug discovery and development. Read the full story

Stallergenes S.A. (Paris:GENP), worldwide leader in allergen immunotherapy, and DBV Technologies (Euronext Paris: DBV), creator of Viaskin(R) for the treatment of allergies, announced today that they have entered into a research and development agreement for the treatment of birch allergy. Read the full story

London, UK, 10 October 2013: MRC Technology, a technology transfer organisation, announced today it is collaborating with Boston University to develop an anti-IL-16 antibody for use in treatment of inflammatory diseases and Ischaemic Reperfusion Injury (IRI). The project is funded in part through a Biomedical Catalyst award of £577,000, granted to MRC Technology in 2012. Read the full story

Humana pharma deals Eli Lilly and Company in a joint research collaboration aimed at improving the health care of their members and patients. Read the full story

Zealand Pharma announced an exclusive peptide drug research and development collaboration agreement with pharma partners Eli Lilly and Company. Read the full story